Target Bulk QDs Position QT Group as a source of non-toxic ZnSe quantum dots for bulk chemical manufacturing, highlighting the company’s unique production process that addresses toxicity, bulk production, quality, and price to attract industrial buyers seeking scalable nanoparticle solutions.

Industrial Collaboration Leverage QT Group’s lab-scale collaboration with experienced chemical synthesis staff to offer joint development and pilot production opportunities, appealing to customers needing custom synthesis, process validation, and small-to-mid scale deployment.

Low Revenue Upside Target early adopters and strategic partners while QT Group scales, emphasizing fast iteration, proven chemistry expertise, and potential for revenue growth as the company expands from laboratory to bulk markets.

Funding Leverage Use the$450K funding and growth potential to secure co-investments, grants, or customer-funded development programs with value propositions centered on reducing toxicity risks and delivering cost-effective quantum dot solutions.

Competitive Positioning Differentiate from larger peers by stressing non-toxic ZnSe QDs, specialized manufacturing for bulk needs, and competitive pricing, targeting industries with stringent safety and large-volume nanoparticle requirements.